CMND

Clearmind Medicine Inc. - Common Shares (CMND)

About Clearmind Medicine Inc. - Common Shares (CMND)

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Details

Daily high

$1.75

Daily low

$1.58

Price at open

$1.74

52 Week High

$524.00

52 Week Low

$1.43

Market cap

2.6M

Dividend yield

0.00%

Volume

69,264

Avg. volume

403,578

P/E ratio

-.01

Clearmind Medicine Inc. - Common Shares News